IndieBio is a venture capital firm and accelerator program focused on funding and supporting early-stage biotech startups.

IndieBio

CRISPR Biotech Engineering is an early-stage genome editing company that is committed to using innovative CRISPR-Cas9 technology to improve human lives.

CRISPR Biotech Engineering

SOSV

IndieBio, an @SOSV startup development program, helps the best scientists become entrepreneurs who build breakthrough companies. http://IndieBio.co

Jungla

Circularis Biotechnologies

Amaryllis Nucleics

Aminolabs

Last night, SOSV's IndieBio, Ontario Government | Gouvernement de l’Ontario’s Trade & Investment Office, and Singapore Economic Development Board (EDB) co-hosted an insightful panel discussion on the importance of building a global company from day one, moderated by Stephen Chambers. 

We heard from 2X fabulous deep tech startup founders - Steve George, CEO Terra Bioindustries and Oliver Worsley, PhD, CEO of Sequential - The Skin Microbiome Testing Co™ - who shared their strategies for growth through global ecosystems. 

CJ Lim, Singapore EDB's Regional Director and Aaron Joshua Pinto, Consul & Senior Economic Officer at Ontario Trade & Investment Office in New York each shared valuable insights on how national and regional economic development organizations can provide invaluable support for founders along the way.

Thank you ACE for your partnership and making this event possible, and to all of our co-organizers Rovik Robert Charley Ford Aaron Joshua Pinto CJ Lim Madeline Behr 🌏

I tasted cultured meat made using light instead of growth factors and got to spend time with the *very* smart founders of Prolific Machines, Inc. Deniz Kent, PhD Declan Jones and Max Huisman. I'll be linking to a PDF of my story for The Information in my next newsletter, which you can sign up for here:  https://lnkd.in/gsGU4aSW cc Nicki Heverling Briggs, MS, RDN Eric Schulze, PhD

After four years working behind the scenes, today Prolific Machines unveils our first-of-its-kind biotechnology platform to the world.

Prolific is the first to use light — safe and abundant — to produce everyday essentials, from nutritional proteins and lifesaving drugs to cultivated meat. Our photomolecular biology platform delivers unprecedented control, precisely guiding cellular behavior when and where it matters most.

This technology debut is coupled with the close of our milestone $55M Series B1 fundraise, led by Ki Tua Fund CVC of Fonterra Co-operative Group. We could not be more grateful to partner with Ki Tua Fund on this journey and for the continued support of our long-time investors Breakthrough Energy Cooper Rinzler Mayfield Fund Arvind Gupta IndieBio Po Bronson SOSV Continental Grain Company Shorewind Capital Darco Capital In-Q-Tel (IQT) Robert Downey Jr.'s FootPrint Coalition Matthew Katz and many more.

This announcement marks our next chapter as a commercial organization. We are excited to unveil partnerships with industry leaders in cellular agriculture, pharmaceuticals, nutritional proteins, and beyond. Stay tuned for details in the coming months, and get in touch at partners@prolific-machines.com if you're interested in co-developing the future of biology with us. 

A huge thank you to our amazing team for making today a reality and helping us illuminate biology’s limitless potential for a healthier, more sustainable tomorrow.

BIG NEWS 📣 Our Nut-Free Spreads have been named a winner in this year's Fast Company World Changing Ideas awards! #FCWorldChangingIdeas

All of us on #TeamVoyage are incredibly honored to see our future-proof & allergy-friendly foods make this prestigious list! 

https://lnkd.in/gTkfNYQ6

Join us for IndieBio's Next Wave where we are helping VCs line up in-person meetings with our founders during the week of June 17 at IndieBio SF’s office in San Francisco.

Can’t make it to San Francisco? No worries! We are also having a virtual demo day on Friday, June 21, at 9:00 a.m. PT.

Learn more and register now! - https://lnkd.in/e6dd2ME9

cc: Po Bronson, Westley Dang, PhD, Parikshit Sharma, Catherine Seo, Sierra Brooks, Alex Kopelyan, Pae Wu

#cohort15 #indiebiosf #investormeetings #deeptechstartups #humanhealth #planetaryhealth

Metric
Company Name	IndieBio	CRISPR Biotech Engineering
Symbol
MSH ID	CO:INDIEBIO	COM:CRISPR-BTE
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services
Industry	Venture Capital	Biotechnology
Country	US	GB
Stage
Employee Count	52
Website	indiebio.co	crispr-bte.com
LinkedIn	indiebio
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	7.61K
Web Traffic Growth	1.47
Valuation
Raised Capital	25M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

INDI

CO:INDIEBIO

IndieBio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue